recent
outbreak
coronaviru
diseas
caus
infect
wuhan
china
pose
seriou
threat
global
public
health
develop
specif
anticoronaviru
therapeut
prophylact
molecular
mechan
underli
viral
infect
must
first
confirm
therefor
herein
use
spike
proteinmedi
cellcel
fusion
assay
found
show
plasma
membran
fusion
capac
superior
sarscov
solv
xray
crystal
structur
sixhel
bundl
core
domain
protein
subunit
reveal
sever
mutat
amino
acid
residu
domain
may
associ
enhanc
interact
domain
previous
develop
pancoronaviru
fusion
inhibitor
target
domain
could
inhibit
infect
diverg
human
coronavirus
test
includ
sarscov
merscov
gener
seri
lipopeptid
found
potent
fusion
inhibitor
proteinmedi
membran
fusion
pseudoviru
infect
ic
nm
potent
peptid
respect
also
highli
effect
membran
fusion
infect
human
coronaviru
pseudovirus
test
includ
sarscov
merscov
well
sarsrcov
potent
inhibit
replic
live
human
coronavirus
includ
intranas
applic
challeng
protect
mice
infect
suggest
could
use
prevent
treatment
infect
current
circul
emerg
sarsrcov
includ
death
report
china
countri
pose
seriou
threat
global
public
health
thu
call
prompt
develop
specif
anticoronaviru
therapeut
prophylact
treatment
prevent
coronavirus
cov
largest
rna
virus
identifi
far
belong
coronavirida
famili
divid
genera
divid
b
c
lineag
seven
cov
infect
human
hcov
includ
lineag
sarscov
lineag
b
coronavirus
merscov
lineag
c
develop
specif
fusion
inhibitor
essenti
studi
fusion
capac
compar
sarscov
particularli
spike
protein
subunit
solv
xray
crystal
structur
core
identifi
sever
mutat
amino
acid
residu
domain
respons
enhanc
interact
domain
conjug
cholesterol
molecul
peptid
found
one
lipopeptid
exhibit
highli
potent
inhibitori
activ
smediat
membran
fusion
psv
infect
potent
peptid
respect
also
highli
effect
vitro
vivo
infect
live
hcov
merscov
suggest
potenti
develop
pancov
fusion
inhibitorbas
therapeut
prophylact
treatment
prevent
infect
current
circul
merscov
well
futur
reemerg
sarscov
emerg
sarsrcov
result
capac
proteinmedi
membran
fusion
gisaid
platform
http
platformgisaidorg
obtain
fulllength
aminoacid
sequenc
betacov
protein
genbank
align
sarscov
slcov
protein
locat
function
domain
protein
contain
subunit
subunit
cleavag
site
subunit
locat
within
ntermin
amino
acid
protein
contain
ntermin
domain
ntd
receptor
bind
domain
rbd
receptor
bind
motif
rbm
subunit
contain
fusion
peptid
fp
heptad
repeat
heptad
repeat
transmembran
domain
tm
cytoplasm
domain
cp
fig
recent
biophys
structur
evid
show
protein
bind
higher
affin
sarscov
protein
suggest
higher
infect
new
viru
unlik
coronavirus
protein
harbor
special
furinrecogniz
site
indic
protein
might
possess
uniqu
infecti
properti
inde
live
authorfund
right
reserv
reus
allow
without
permiss
april
world
health
organ
establish
prioriti
list
pathogen
includ
middl
east
respiratori
syndrom
mer
sever
acut
respiratori
syndrom
sar
diseas
x
diseas
epidem
pandem
potenti
caus
unknown
pathogen
late
decemb
outbreak
pneumonia
unknown
etiolog
wuhan
china
consid
first
diseas
x
follow
announc
shortli
thereaft
novel
coronaviru
denot
identifi
pathogen
caus
coronaviru
diseas
sequenc
ident
sarscov
bat
coronaviru
respect
renam
mediat
membran
fusion
sequenc
ident
sequenc
similar
sarscov
util
human
angiotensinconvert
enzym
receptor
infect
human
cell
importantli
affin
receptorbind
domain
rbd
subunit
protein
higher
sarscov
may
contribut
higher
infect
transmiss
compar
sarscov
howev
unclear
whether
mediat
membran
fusion
manner
exce
capac
sarscov
bind
rbd
subunit
protein
virion
receptor
target
cell
heptad
repeat
domain
subunit
protein
interact
form
sixhelix
bundl
fusion
core
bring
viral
cellular
membran
close
proxim
fusion
infect
therefor
fusion
core
structur
sarscov
protein
also
compar
order
investig
structur
basi
membran
fusion
mediat
protein
thu
set
stage
ration
design
coronaviru
fusion
inhibitor
previou
studi
design
pancoronaviru
fusion
inhibitor
target
domain
hcov
protein
prove
effect
studi
shown
exhibit
much
higher
capac
membran
fusion
sarscov
suggest
fusion
machineri
infect
found
typic
syncytium
phenomenon
natur
form
infect
cell
rare
report
sarscov
infect
fig
explor
special
characterist
infect
clone
gene
paaviresgfp
vector
establish
smediat
cellcel
fusion
system
use
cell
express
protein
egfp
effector
cell
cell
express
human
receptor
target
cell
fig
fig
effector
cell
target
cell
cocultur
h
fuse
cell
show
least
larger
size
normal
cell
multipl
nuclei
cell
observ
group
sarscov
group
coincub
h
hundr
target
cell
fuse
togeth
one
big
syncytium
contain
multipl
nuclei
fig
anoth
later
syncytium
grew
bigger
could
easili
previous
identifi
form
domain
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
subunit
play
import
role
membran
fusion
process
mediat
merscov
sarscov
protein
similarli
recent
studi
suggest
subunit
also
interact
form
coiledcoil
complex
support
membran
fusion
viral
infect
fig
fig
howev
specif
bind
characterist
remain
explor
understand
structur
basi
interact
region
fusion
protein
contain
major
part
residu
residu
flexibl
linker
sggrgg
construct
crystallograph
studi
crystal
structur
show
canon
structur
rodlik
shape
length
diamet
fig
fig
hydrophob
interact
mainli
locat
helic
fusion
core
region
discuss
later
overal
structur
similar
hcov
rootmeansquar
deviat
rmsd
sarscov
merscov
atom
fig
find
suggest
overal
conform
import
highli
conserv
compon
danger
coronavirus
compar
common
coronavirus
caus
mild
respiratori
diseas
similar
overal
structur
except
differ
length
helix
domain
form
longer
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
bend
helix
interact
trimer
core
fig
relationship
structur
differ
pathogen
hcov
remain
elucid
accord
sequenc
align
subunit
sarscov
highli
conserv
overal
homolog
weak
salt
bridg
distanc
mutat
bind
domain
salt
bridg
distanc
fig
sarscov
bind
salt
bridg
distanc
involv
interact
howev
mutat
could
bind
domain
hydrogen
bond
distanc
could
also
bind
salt
bridg
distanc
fig
result
suggest
multipl
replac
domain
emerg
viru
could
enhanc
interact
domain
stabil
structur
may
lead
increas
infect
viru
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
design
structureact
relationship
sar
analysi
lipopeptid
remark
improv
fusion
inhibitori
activ
previous
found
peptid
could
disturb
viral
format
respect
fig
meanwhil
peptid
show
inhibitori
activ
concentr
fig
result
strongli
suggest
lipid
promis
strategi
improv
fusioninhibitori
activ
infect
especi
cholesterolmodif
basi
structur
seri
cholesteryl
multipl
linker
construct
glycineserinebas
linker
ie
gsg
pegbas
spacer
employ
cholesterol
moieti
fig
compar
show
similar
inhibitori
activ
strikingli
peptid
acid
linker
gsg
spacer
exhibit
potenc
noteworthi
chang
gsg
longer
acid
linker
gsgsg
significantli
increas
inhibitori
potenc
hybrid
molecul
ic
valu
nm
potent
find
indic
linker
length
signific
effect
overal
activ
lipopeptid
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
comparison
increas
pegbas
arm
length
show
inhibitor
potenc
slightli
decreas
cellcel
fusion
assay
fig
data
suggest
linker
optim
bridg
part
conjug
similarli
show
potent
inhibitori
activ
psv
infect
ic
valu
nm
provid
stronger
activ
ic
nm
fig
lipopeptid
exhibit
potent
inhibitori
activ
fusion
process
mediat
protein
could
also
significantli
prevent
ic
rang
nm
well
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ek
ic
rang
nm
fig
h
control
peptid
show
inhibitori
activ
concentr
coronaviru
cellcel
fusion
assay
fig
also
assess
antivir
activ
psv
infect
diverg
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
cc
beyond
highest
detect
concentr
fig
therefor
select
index
sicc
ic
suggest
promis
fusion
inhibitor
littl
even
toxic
effect
vitro
explor
potent
antivir
mechan
found
complex
harbor
higher
stabil
increas
tm
valu
complex
form
fig
result
suggest
increas
antivir
activ
relat
increas
bind
affin
detail
interact
requir
studi
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
test
therapeut
effect
h
group
h
group
infect
fig
group
group
mice
show
surviv
rate
respect
suggest
harbor
good
therapeut
effect
short
period
infect
possibl
result
establish
infect
mous
brain
get
blood
brain
barrier
via
nasal
administr
shown
fig
high
viral
titer
detect
brain
mice
group
mice
group
detect
brain
tissu
mice
group
moder
level
viral
titer
detect
brain
tissu
one
mice
group
fig
b
induc
furinrecognit
site
could
significantli
increas
capac
sarscov
protein
mediat
cellular
membran
surfac
infect
interestingli
harbor
cleavag
site
protein
specif
role
proteinmedi
membran
fusion
viral
lifecycl
remain
explor
fig
recent
report
suggest
mainli
use
plasma
membran
fusion
mean
inhibitor
might
constitut
option
block
fusion
entri
host
cell
structur
form
region
subunit
hcov
play
key
role
viral
membran
fusion
process
make
one
import
target
drug
design
previou
studi
found
could
form
stabl
coiledcoil
complex
detail
conform
remain
unknown
accord
xray
crystallograph
analysi
complex
form
fig
typic
howev
instead
weaken
interact
unilater
differ
seem
form
new
interact
region
enhanc
exist
one
region
fig
sarscov
replac
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
new
strong
hydrogen
bond
form
distanc
form
new
interact
distanc
wherea
correspond
posit
sarscov
interact
two
region
bind
bind
sarscov
enhanc
result
suggest
new
hcov
evolv
improv
bind
affin
domain
may
acceler
viral
membran
fusion
process
enhanc
viral
infect
transmiss
recent
studi
also
found
bind
affin
receptor
host
cell
rbd
protein
higher
sarscov
may
also
associ
increas
infect
transmiss
conjug
cholesterol
viral
entri
inhibitor
prove
effect
strategi
enhanc
antivir
activ
peptid
howev
mechan
enhanc
especi
role
cholesterol
group
ctermin
tail
entri
inhibitor
still
unclear
possibl
cholesterol
group
could
anchor
target
membran
facilit
bind
inhibitor
target
howev
notic
bind
affin
significantli
enhanc
peptid
alon
suggest
cholesterol
group
may
involv
bind
directli
fig
therefor
use
structur
simul
dock
method
predict
possibl
model
bind
fig
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
past
decad
viral
domain
prove
import
administ
intranas
h
challeng
h
challeng
mice
challeng
intranas
hcov
dose
viral
control
group
volum
hbc
pb
administ
intranas
group
six
mice
randomli
select
euthanasia
day
infect
five
mice
collect
assess
viral
titer
mous
brain
one
mous
brain
histolog
examin
bodi
weight
surviv
remain
six
mice
group
monitor
day
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
cytotox
assay
cytotox
peptid
cell
rd
cell
test
use
cell
count
briefli
cell
type
seed
well
microtit
plate
per
well
incub
h
replac
medium
dmed
contain
grade
concentr
cultur
day
solut
per
well
predict
swissmodel
sever
use
refer
moieti
autodock
softwar
cholesterol
moieti
fig
refer
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
